Back to Search
Start Over
Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis.
- Source :
-
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2019 Nov; Vol. 30 (11), pp. 2140-2157. Date of Electronic Publication: 2019 Aug 23. - Publication Year :
- 2019
-
Abstract
- Background Because of their capacity to induce antigen-specific immunosuppression, tolerogenic dendritic cells are a promising tool for treatment of autoimmune conditions, such as GN caused by autoimmunity against myeloperoxidase (MPO).<br />Methods: We sought to generate tolerogenic dendritic cells to suppress anti-MPO GN by culturing bone marrow cells with an NF κ B inhibitor (BAY 11-7082) and exposing them to a pulse of MPO. After administering these MPO/BAY dendritic cells or saline to mice with established anti-MPO or anti-methylated BSA (mBSA) immunity, we assessed immune responses and GN. We also examined mechanisms of action of MPO/BAY dendritic cells.<br />Results: MPO/BAY dendritic cells decreased anti-MPO immunity and GN without inhibiting immune responses against mBSA; they also induced IL-10-producing regulatory T cells in MPO-immunized mice without affecting IL-10 <superscript>+</superscript> CD4 <superscript>+</superscript> Foxp3 <superscript>-</superscript> type 1 regulatory T cells or regulatory B cells. MPO/BAY dendritic cells did not inhibit anti-MPO immunity when CD4 <superscript>+</superscript> Foxp3 <superscript>+</superscript> cells were depleted in vivo , showing that regulatory T cells are required for their effects. Coculture experiments with dendritic cells and CD4 <superscript>+</superscript> Foxp3 <superscript>-</superscript> or CD4 <superscript>+</superscript> Foxp3 <superscript>+</superscript> cells showed that MPO/BAY dendritic cells generate Foxp3 <superscript>+</superscript> regulatory T cells from CD4 <superscript>+</superscript> Foxp3 <superscript>-</superscript> cells through several pathways, and induce IL-10 <superscript>+</superscript> regulatory T cells via inducible costimulator (ICOS), which was confirmed in vivo . Transfer of MPO/BAY dendritic cell-induced regulatory T cells in vivo , with or without anti-IL-10 receptor antibody, demonstrated that they suppress anti-MPO immunity and GN via IL-10.<br />Conclusions: MPO/BAY dendritic cells attenuate established anti-MPO autoimmunity and GN in an antigen-specific manner through ICOS-dependent induction of IL-10-expressing regulatory T cells. This suggests that autoantigen-loaded tolerogenic dendritic cells may represent a novel antigen-specific therapeutic option for anti-MPO GN.<br /> (Copyright © 2019 by the American Society of Nephrology.)
- Subjects :
- Animals
Immune Tolerance
Inducible T-Cell Co-Stimulator Protein physiology
Interleukin-10 biosynthesis
Male
Mice
Mice, Inbred C57BL
NF-kappa B antagonists & inhibitors
Nitriles therapeutic use
Sulfones therapeutic use
T-Lymphocytes, Regulatory immunology
Vasculitis therapy
Dendritic Cells immunology
Diabetes Mellitus, Type 1 therapy
Glomerulonephritis therapy
Peroxidase immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1533-3450
- Volume :
- 30
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Journal of the American Society of Nephrology : JASN
- Publication Type :
- Academic Journal
- Accession number :
- 31444274
- Full Text :
- https://doi.org/10.1681/ASN.2019030236